Return to Listing

2 result(s) for

PI Name Protocol # Title
Lara Davis IRB00010529 SARC024: A blanket protocol to study oral regorafenib in patients with selected sarcoma subtypes
Michael Heinrich STUDY00018437 An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080